Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation
- 1 January 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 9 (1) , 14-23
- https://doi.org/10.1007/bf01969527
Abstract
The effect of suppression with antimicrobial agents of the intestinal microflora of paediatric bone marrow graft recipients on severe bacterial and fungal infections and on moderate to severe acute graft-versus-host disease was studied retrospectively. Data on 65 cases of bone marrow transplantation for either severe bone marrow failure or leukaemia, performed in a strict protective environment with either complete or selective gastrointestinal decontamination, were evaluated. All bone marrow grafts were from HLA-identical siblings and were not depleted of T-lymphocytes. Twenty percent of the recipients had one or more episodes of septicaemia during the granulocytopenic period after transplantation, mostly due to gram-positive bacteria. Only five children died due to infection, in each case caused by a microorganism originating from the endogenous flora. Complete gastrointestinal decontamination was superior to selective gastrointestinal decontamination in preventing infectious complications (p<0.001). The same was the case for the prevention of acute graft-versus-host disease of grade II or higher, which was observed in 7 of 40 (17.5 %) completely decontaminated children versus 9 of 18 (50 %) selectively decontaminated children evaluable for graft-versus-host disease (p<0.01). It is concluded that complete gastrointestinal decontamination in a strict protective environment is a feasible and very effective method for preventing severe infections and acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents; it resulted in a low transplantation-related mortality of 26 % and a good quality of survival in 69 % of the graft recipients.This publication has 42 references indexed in Scilit:
- Risk factors for acute graft‐versus‐host diseaseBritish Journal of Haematology, 1987
- Protein loss during acute graft‐versus‐host disease: Diagnostic and clinical significanceEuropean Journal of Haematology, 1987
- Strict Protective Isolation in Allogeneic Bone Marrow Transplantation: Effect on Infectious Complications, Fever and Graft Versus Host DiseaseScandinavian Journal of Infectious Diseases, 1987
- Alpha-Hemolytic Streptococcal Septicemia with Severe Complications During Neutropenia in Childhood CancerPediatric Hematology and Oncology, 1987
- Infections in bone marrow transplant recipientsThe Journal of Pediatrics, 1986
- Graft‐versus‐Host Disease in Dog and Man: The Seattle ExperienceImmunological Reviews, 1985
- STREPTOCOCCAL SEPSIS IN BONE MARROW TRANSPLANT PATIENTSThe Lancet, 1984
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsNew England Journal of Medicine, 1983
- RANDOMIZED TRIAL OF PROTECTED ENVIRONMENT — PROPHYLACTIC ANTIBIOTICS IN 145 ADULTS WITH ACUTE LEUKEMIAMedicine, 1978
- METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTSTransplantation, 1970